{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:26:21Z","timestamp":1791401181786,"version":"4.3.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T00:00:00Z","timestamp":1410220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1007\/s40266-014-0206-0","type":"journal-article","created":{"date-parts":[[2014,9,8]],"date-time":"2014-09-08T10:03:33Z","timestamp":1410170613000},"page":"769-776","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Adverse Drug Reactions in Elderly Subjects Hospitalized in a Specialized Dementia Management Unit"],"prefix":"10.1007","volume":"31","author":[{"given":"Lukshe","family":"Kanagaratnam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachid","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Novella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moustapha","family":"Dram\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Trenque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,9]]},"reference":[{"key":"206_CR1","unstructured":"Alzheimer\u2019s Disease International. World alzheimer report 2011: the benefits of early diagnosis and intervention. Available from: http:\/\/www.alz.co.uk\/research\/world-report-2011 ."},{"issue":"6","key":"206_CR2","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1159\/000101454","volume":"23","author":"H Ganjavi","year":"2007","unstructured":"Ganjavi H, Herrmann N, Rochon PA, et al. Adverse drug events in cognitively impaired elderly patients. Dement Geriatr Cogn Disord. 2007;23(6):395\u2013400.","journal-title":"Dement Geriatr Cogn Disord."},{"issue":"12","key":"206_CR3","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1001\/jama.288.12.1475","volume":"288","author":"CG Lyketsos","year":"2002","unstructured":"Lyketsos CG, Lopez O, Jones B, et al. Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA. 2002;288(12):1475\u201383.","journal-title":"JAMA."},{"issue":"5","key":"206_CR4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1176\/appi.ajp.157.5.708","volume":"157","author":"CG Lyketsos","year":"2000","unstructured":"Lyketsos CG, Steinberg M, Tschanz JT, et al. Mental and behavioral disturbances in dementia: findings from the Cache County Study on Memory in Aging. Am J Psychiatry. 2000;157(5):708\u201314.","journal-title":"Am J Psychiatry."},{"issue":"3","key":"206_CR5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1532-5415.2011.03314.x","volume":"59","author":"T Okura","year":"2011","unstructured":"Okura T, Plassman BL, Steffens DC, et al. Neuropsychiatric symptoms and the risk of institutionalization and death: the Aging, Demographics, and Memory Study. J Am Geriatr Soc. 2011;59(3):473\u201381.","journal-title":"J Am Geriatr Soc."},{"issue":"Suppl 8","key":"206_CR6","first-page":"43","volume":"61","author":"PS Masand","year":"2000","unstructured":"Masand PS. Side effects of antipsychotics in the elderly. J Clin Psychiatry. 2000;61(Suppl 8):43\u20139 (discussion 50\u201351).","journal-title":"J Clin Psychiatry."},{"key":"206_CR7","unstructured":"Mesures\u2014plan alzheimer 2008\u20132012. Available from: http:\/\/www.plan-alzheimer.gouv.fr\/-44-mesures-.html ."},{"issue":"71","key":"206_CR8","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.npg.2012.07.005","volume":"12","author":"R Mahmoudi","year":"2012","unstructured":"Mahmoudi R, Dram\u00e9 M, Morrone I, et al. Une unit\u00e9 de soins aigus pour les patients atteints de la maladie d\u2019Alzheimer et syndromes apparent\u00e9s: l\u2019exp\u00e9rience r\u00e9moise. Neurol Psychiatr G\u00e9riatr. 2012;12(71):230\u20136.","journal-title":"Neurol Psychiatr G\u00e9riatr."},{"key":"206_CR9","first-page":"143","volume-title":"Diagnostic and statistical manual of mental disorders. 4th ed.","author":"American Psychiatric Association","year":"1994","unstructured":"American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association; 1994. p. 143\u20137."},{"key":"206_CR10","volume-title":"Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre","author":"WHO Collaborating Centre for International Drug Monitoring (UMC)","year":"2000","unstructured":"WHO Collaborating Centre for International Drug Monitoring (UMC). Safety monitoring of medicinal products: guidelines for setting up and running a pharmacovigilance centre. London: EQUUS; 2000."},{"key":"206_CR11","unstructured":"Directive 2000\/38\/CE de la Commission du 5 juin 2000 modifiant le chapitre V bis (Pharmacovigilance) de la directive 75\/319\/CEE du Conseil concernant le rapprochement des dispositions l\u00e9gislatives, r\u00e9glementaires et administratives relatives aux sp\u00e9cialit\u00e9s pharmaceutiques (Texte pr\u00e9sentant de l\u2019int\u00e9r\u00eat pour l\u2019EEE). Available from: http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Regulatory_and_procedural_guideline\/2009\/10\/WC500004481.pdf ."},{"issue":"3","key":"206_CR12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","volume":"12","author":"MF Folstein","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \u00a0Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12(3):189\u201398.","journal-title":"J Psychiatr Res."},{"issue":"1","key":"206_CR13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000180580","volume":"16","author":"DW Cockcroft","year":"1976","unstructured":"Cockcroft DW, Gault H. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31\u201341.","journal-title":"Nephron."},{"issue":"9","key":"206_CR14","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jclinepi.2012.02.018","volume":"65","author":"D Gnjidic","year":"2012","unstructured":"Gnjidic D, Hilmer SN, Blyth FM, et al. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. J Clin Epidemiol. 2012;65(9):989\u201395.","journal-title":"J Clin Epidemiol."},{"key":"206_CR15","unstructured":"ANSM: agence nationale de s\u00e9curit\u00e9 du m\u00e9dicament et des produits de sant\u00e9. Interactions m\u00e9dicamenteuses. Available from: http:\/\/ansm.sante.fr\/Dossiers-thematiques\/Interactions-medicamenteuses\/Interactions-medicamenteuses\/(offset)\/0 ."},{"key":"206_CR16","doi-asserted-by":"crossref","unstructured":"Hosmer DW, Lemeshow S. Applied logistic regression. 2nd ed. New York: Wiley; 2000.","DOI":"10.1002\/0471722146"},{"issue":"1","key":"206_CR17","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.archger.2004.05.005","volume":"40","author":"F Caama\u00f1o","year":"2005","unstructured":"Caama\u00f1o F, Pedone C, Zuccal\u00e0 G, et al. Socio-demographic factors related to the prevalence of adverse drug reaction at hospital admission in an elderly population. Arch Gerontol Geriatr. 2005;40(1):45\u201352.","journal-title":"Arch Gerontol Geriatr."},{"issue":"9","key":"206_CR18","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2165\/00002512-200522090-00005","volume":"22","author":"MCG Passarelli","year":"2005","unstructured":"Passarelli MCG, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging. 2005;22(9):767\u201377.","journal-title":"Drugs Aging."},{"issue":"9","key":"206_CR19","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1002\/pds.3471","volume":"22","author":"ML Laroche","year":"2013","unstructured":"Laroche ML, Perault-Pochat MC, Ingrand I, et al. French Centres of Pharmacovigilance Network. Adverse drug reactions in patients with Alzheimer\u2019s disease and related dementia in France: a national multicentre cross-sectional study. Pharmacoepidemiol Drug Saf. 2013;22(9):952\u201360.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"13","key":"206_CR20","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.161.13.1629","volume":"161","author":"TS Field","year":"2001","unstructured":"Field TS, Gurwitz JH, Avorn J, et al. Risk factors for adverse drug events among nursing home residents. Arch Intern Med. 2001;161(13):1629\u201334.","journal-title":"Arch Intern Med."},{"issue":"12","key":"206_CR21","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1046\/j.1532-5415.2002.50607.x","volume":"50","author":"G Onder","year":"2002","unstructured":"Onder G, Pedone C, Landi F, et al. Adverse drug reactions as cause of hospital admissions: results from the Italian Group of Pharmacoepidemiology in the Elderly (GIFA). J Am Geriatr Soc. 2002;50(12):1962\u20138.","journal-title":"J Am Geriatr Soc."},{"issue":"3","key":"206_CR22","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.jalz.2012.01.002","volume":"9","author":"SD Rountree","year":"2013","unstructured":"Rountree SD, Atri A, Lopez OL, et al. Effectiveness of antidementia drugs in delaying Alzheimer\u2019s disease progression. Alzheimers Dement. 2013;9(3):338\u201345.","journal-title":"Alzheimers Dement."},{"issue":"Suppl 13","key":"206_CR23","first-page":"S346","volume":"17","author":"A Atri","year":"2011","unstructured":"Atri A. Effective pharmacological management of Alzheimer\u2019s disease. Am J Manag Care. 2011;17(Suppl 13):S346\u201355.","journal-title":"Am J Manag Care."},{"issue":"9","key":"206_CR24","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1001\/jama.289.9.1107","volume":"289","author":"JH Gurwitz","year":"2003","unstructured":"Gurwitz JH, Field TS, Harrold LR, et al. Incidence and preventability of adverse drug events among older persons in the ambulatory setting. JAMA. 2003;289(9):1107\u201316.","journal-title":"JAMA."},{"issue":"11","key":"206_CR25","doi-asserted-by":"crossref","first-page":"933","DOI":"10.2165\/0002512-200825110-00004","volume":"25","author":"M Prudent","year":"2008","unstructured":"Prudent M, Dram\u00e9 M, Jolly D, et al. Potentially inappropriate use of psychotropic medications in hospitalized elderly patients in France: cross-sectional analysis of the prospective, multicentre SAFEs cohort. Drugs Aging. 2008;25(11):933\u201346.","journal-title":"Drugs Aging."},{"issue":"Suppl 21","key":"206_CR26","first-page":"11","volume":"62","author":"LE Tune","year":"2001","unstructured":"Tune LE. Anticholinergic effects of medication in elderly patients. J Clin Psychiatry. 2001;62(Suppl 21):11\u20134.","journal-title":"J Clin Psychiatry."},{"key":"206_CR27","doi-asserted-by":"crossref","unstructured":"Ballard C, Waite J. The effectiveness of atypical antipsychotics for the treatment of aggression and psychosis in Alzheimer\u2019s disease. Cochrane Database Syst Rev. 2006;(1):CD003476.","DOI":"10.1002\/14651858.CD003476.pub2"},{"issue":"8","key":"206_CR28","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00228-007-0324-2","volume":"63","author":"M-L Laroche","year":"2007","unstructured":"Laroche M-L, Charmes J-P, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725\u201331.","journal-title":"Eur J Clin Pharmacol."},{"issue":"4","key":"206_CR29","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1371\/journal.pmed.0050076","volume":"5","author":"C Ballard","year":"2008","unstructured":"Ballard C, Lana MM, Theodoulou M, et al. Investigators DART AD. A randomised, blinded, placebo-controlled trial in dementia patients continuing or stopping neuroleptics (the DART-AD trial). PLoS Med. 2008;5(4):e76.","journal-title":"PLoS Med."},{"issue":"5","key":"206_CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1097\/MNH.0b013e32834902ad","volume":"20","author":"ZA Marcum","year":"2011","unstructured":"Marcum ZA, Fried LF. Aging and antihypertensive medication-related complications in the chronic kidney disease patient. Curr Opin Nephrol Hypertens. 2011;20(5):449\u201356.","journal-title":"Curr Opin Nephrol Hypertens."},{"issue":"12","key":"206_CR31","first-page":"1255","volume":"96","author":"B Tipping","year":"2006","unstructured":"Tipping B, Kalula S, Badri M. The burden and risk factors for adverse drug events in older patients: a prospective cross-sectional study. S Afr Med J. 2006;96(12):1255\u20139.","journal-title":"S Afr Med J."},{"issue":"4","key":"206_CR32","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amjopharm.2007.12.002","volume":"5","author":"ER Hajjar","year":"2007","unstructured":"Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345\u201351.","journal-title":"Am J Geriatr Pharmacother."},{"issue":"4","key":"206_CR33","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1046\/j.1365-2125.1998.t01-1-00768.x","volume":"46","author":"TJ Campbell","year":"1998","unstructured":"Campbell TJ, Williams KM. Therapeutic drug monitoring: antiarrhythmic drugs. Br J Clin Pharmacol. 1998;46(4):307\u201319.","journal-title":"Br J Clin Pharmacol."},{"issue":"1","key":"206_CR34","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.amjopharm.2006.03.002","volume":"4","author":"JK Nguyen","year":"2006","unstructured":"Nguyen JK, Fouts MM, Kotabe SE, et al. Polypharmacy as a risk factor for adverse drug reactions in geriatric nursing home residents. Am J Geriatr Pharmacother. 2006;4(1):36\u201341.","journal-title":"Am J Geriatr Pharmacother."},{"issue":"13","key":"206_CR35","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archinternmed.2010.153","volume":"170","author":"G Onder","year":"2010","unstructured":"Onder G, Petrovic M, Tangiisuran B, et al. Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65\u00a0years or older: the GerontoNet ADR risk score. Arch Intern Med. 2010;170(13):1142\u20138.","journal-title":"Arch Intern Med."},{"issue":"12","key":"206_CR36","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1002\/pds.2224","volume":"20","author":"W Hoffmann","year":"2011","unstructured":"Hoffmann W, van den Berg N, Thyrian JR, et al. Frequency and determinants of potential drug\u2013drug interactions in an elderly population receiving regular home visits by GPs: results of the home medication review in the AGnES-studies. Pharmacoepidemiol Drug Saf. 2011;20(12):1311\u20138.","journal-title":"Pharmacoepidemiol Drug Saf."},{"issue":"6","key":"206_CR37","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/pds.1351","volume":"16","author":"ML Becker","year":"2007","unstructured":"Becker ML, Kallewaard M, Caspers PWJ, et al. Hospitalisations and emergency department visits due to drug\u2013drug interactions: a literature review. Pharmacoepidemiol Drug Saf. 2007;16(6):641\u201351.","journal-title":"Pharmacoepidemiol Drug Saf."}],"container-title":["Drugs &amp; Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-014-0206-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-014-0206-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,16]],"date-time":"2022-04-16T14:37:25Z","timestamp":1650119845000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-014-0206-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,9]]},"references-count":37,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["206"],"URL":"https:\/\/doi.org\/10.1007\/s40266-014-0206-0","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,9]]}}}